Dr. Carlton Donald was invited to present Phigenix’s cutting-edge breast and prostate cancer technology at the 2023 MedLab Middle East Conference. The four-day conference was held at the Dubai World Trade Center. Dr Donald commented, “Engaging with companies, government agencies, and other scientists was refreshing and enlightening. I look forward to collaborating with our new contacts in the region.”
Phigenix CEO Dr. Carlton Donald Gives Presentation at the 2023 MedLab Middle East Conference in Dubai
Previous
Previous
Stanford University Study Confirms the Use of Human Beta Defensin-1 (hBD-1) as a Potential Adjuvant Therapy for Breast Cancer
Next
Next